PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 63 filers reported holding PROQR THRAPEUTICS N V in Q1 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,922,570 | $19,053,000 | 7.16% |
| DAFNA Capital Management LLC | 1,114,000 | $11,040,000 | 3.79% |
| RTW INVESTMENTS, LP | 4,779,135 | $47,361,000 | 1.79% |
| Kerrisdale Advisers, LLC | 448,880 | $4,448,000 | 1.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 805,000 | $7,978,000 | 0.66% |
| Artal Group S.A. | 1,300,000 | $12,883,000 | 0.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,571,319 | $45,302,000 | 0.11% |
| ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $2,194,000 | 0.09% |
| COWEN AND COMPANY, LLC | 103,727 | $1,028,000 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 60,000 | $595,000 | 0.07% |